Thrombocytopenia in pregnancy: Diagnosis and approach to management
- PMID: 31757523
- DOI: 10.1016/j.blre.2019.100638
Thrombocytopenia in pregnancy: Diagnosis and approach to management
Abstract
Thrombocytopenia during pregnancy presents unique challenges for the hematologist. Obstetricians generally manage many of the pregnancy-specific etiologies, ranging from the benign (gestational thrombocytopenia) to the life-threatening (preeclampsia; hemolysis, elevated liver enzymes and low platelets syndrome; and acute fatty liver of pregnancy). However, hematologists may be consulted for atypical and severe presentations and to help manage non-pregnancy specific etiologies, including immune thrombocytopenia, thrombotic thrombocytopenic purpura, hemolytic uremic syndrome and antiphospholipid syndrome, among others, in which maternal and fetal risks must be considered. This review provides a general approach to the diagnosis and management of thrombocytopenia in pregnancy for the consulting hematologist.
Keywords: Gestational thrombocytopenia; Hemolytic uremic syndrome; Immune thrombocytopenia; Preeclampsia; Pregnancy; Thrombocytopenia; Thrombotic thrombocytopenic purpura; von Willebrand disease.
Copyright © 2019 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest AP has received an educational grant from Novo Nordisk Inc. DC has served as a consultant or advisory board member for Amgen, Rigel, Novartis, Dova, and CSL has received research support from T2Biosystems, Aplagon, Syntimmune, and Momenta. The other authors have no conflicts to declare.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources